Therapeutic Potential of a Novel Anti-Inflammatory and Anti-Fibrotic Agent, VCP979, for Obesity-Induced Heart Failure With Preserved Ejection FractionB. Wang, V. Jeyakumar, L. Tawk, W. Shihata, H. Kiriazis,D. Donner,B. Kemp-Harper, D. KayeHeart, Lung and Circulation（2022）引用 0|浏览15暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
